1.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 19747-PRIMAL, PRIMAL, NCT00458679
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, NIH WGMCC Protocol IDs: 030162, 03-C-0162, NCI-5855, CDR0000304438, NCT00062036
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MCC-12051, MCC-IRB-5482, VALENTIS-IL2-2001, NCI-G00-1810, NCT00006033
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 80 Sponsor: Other Protocol IDs: U1111-1114-6557, NCT01176552
|
|
5.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: DUMC-93122, NCI-H96-1111
|
|
6.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000582397, BCM-H-11541, BCM-CLIMAT, NCT00609076
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 75 and under Sponsor: Other Protocol IDs: H6408-Leu Leu, NCT00058799
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: H11967, CLIPA, NCT00078520
|